Showing results (121-130 of 496) with videos related to

Sort By:
Pageof 50
Nature Communications|October 23, 2023
Activation of coagulation and proinflammatory pathways in thrombosis with thrombocytopenia syndrome and following COVID-19 vaccinationMalika Aid, Kathryn E Stephenson, Ai-Ris Y Collier, et al.
Open Forum Infectious Diseases|December 10, 2021
US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19Robert W Finberg, Madiha Ashraf, Boris Julg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 2, 2022
Landscape of Human Immunodeficiency Virus Neutralization Susceptibilities Across Tissue ReservoirsChuangqi Wang, Timothy E Schlub, Wen Han Yu, et al.
Elife|April 12, 2021
Distinct clonal evolution of B-cells in HIV controllers with neutralizing antibody breadthDeniz Cizmeci, Giuseppe Lofano, Evan Rossignol, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2015
Programmed cell death 1 and Helios distinguish TCR-αβ+ double-negative (CD4-CD8-) T cells that derive from self-reactive CD8 T cellsNoé Rodríguez-Rodríguez, Sokratis A Apostolidis, Pablo Penaloza-MacMaster, et al.
Nature Materials|January 29, 2013
Polymer multilayer tattooing for enhanced DNA vaccinationPeter C DeMuth, Younjin Min, Bonnie Huang, et al.
Journal of Virology|November 16, 2012
Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectorsPablo Penaloza-MacMaster, Nicholas M Provine, Joshua Ra, et al.
Cell Reports|December 16, 2020
HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral ReboundRasmus Offersen, Wen-Han Yu, Eileen P Scully, et al.
Plos Pathogens|September 6, 2022
Evolution of functional antibodies following acute Epstein-Barr virus infectionChristina B Karsten, Yannic C Bartsch, Sally A Shin, et al.
Nature Medicine|September 12, 2024
Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trialBoris Julg, Victoria E K Walker-Sperling, Kshitij Wagh, et al.
Pageof 50